Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Related Pain (Breakthrough Pain)”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableStudy completedNCT02899884
What this trial is testing

Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

Who this might be right for
Breakthrough Cancer Pain
Takeda 3,765
Testing effectiveness (Phase 2)Ended earlyNCT00351637
What this trial is testing

Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

Who this might be right for
CancerPain
Alberta Health services 60
Large-scale testing (Phase 3)Study completedNCT01326689
What this trial is testing

A Comparative Study of KW-2246

Who this might be right for
Cancer Related Pain (Breakthrough Pain)
Kyowa Kirin Co., Ltd. 42
Post-approval studies (Phase 4)Ended earlyNCT00842829
What this trial is testing

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Who this might be right for
Cancer PainBreakthrough Pain
Cephalon 330
Large-scale testing (Phase 3)Ended earlyNCT00125801
What this trial is testing

The Pain Pen for Breakthrough Cancer Pain

Who this might be right for
NeoplasmsPain
Erasmus Medical Center 50
Not applicableStudy completedNCT02437929
What this trial is testing

Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment

Who this might be right for
Breakthrough PainPain Due to Certain Specified ProceduresPain+2 more
Antea Foundation 1,079
Testing effectiveness (Phase 2)Study completedNCT00345735
What this trial is testing

Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

Who this might be right for
CancerPain
Nycomed 150
Not applicableUnknownNCT01693328
What this trial is testing

Patient Satisfaction and Quality of Life Impact - PecFent®

Who this might be right for
Breakthrough Cancer Pain
Archimedes Development Ltd 300
Not applicableNot Yet RecruitingNCT06790719
What this trial is testing

Paediatric Breakthrough Pain Assessment

Who this might be right for
Breakthrough PainPalliative MedicineOncology Pain+2 more
University of Southampton 210
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableWithdrawnNCT05053308
What this trial is testing

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Who this might be right for
Cancer PainBreakthrough Pain
Seoul National University
Testing effectiveness (Phase 2)Study completedNCT05531422
What this trial is testing

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Who this might be right for
Breakthrough Cancer Pain
Lee's Pharmaceutical Limited 60
Not applicableStudy completedNCT01946555
What this trial is testing

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

Who this might be right for
TumorCancer PainBreakthrough Cancer Pain+1 more
Mario Negri Institute for Pharmacological Research 150
Not applicableStudy completedNCT02836379
What this trial is testing

Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent

Who this might be right for
Breakthrough Pain
Angelini Farmacéutica 79
Post-approval studies (Phase 4)Study completedNCT00576173
What this trial is testing

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Who this might be right for
Pain
Johnson & Johnson Taiwan Ltd 60
Testing effectiveness (Phase 2)UnknownNCT03564548
What this trial is testing

Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain

Who this might be right for
CancerBreakthrough Cancer Pain
Tetra Bio-Pharma 20
Post-approval studies (Phase 4)Ended earlyNCT01812759
What this trial is testing

Fentanyl for Breakthrough Pain in the Emergency Department

Who this might be right for
Pain
M.D. Anderson Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT00589823
What this trial is testing

Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

Who this might be right for
Cancers, Pain
Archimedes Development Ltd 135
Not applicableStudy completedNCT03895762
What this trial is testing

Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients

Who this might be right for
Breakthrough Cancer Pain
A.Menarini Asia-Pacific Holdings Pte Ltd 143
Testing effectiveness (Phase 2)UnknownNCT04713189
What this trial is testing

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain

Who this might be right for
Breakthrough Cancer Pain
Lee's Pharmaceutical Limited 96
Load More Results